Is Attending The Annual J.P. Morgan Healthcare Conference In-Person Worth It?

Source: Life Science Leader

In this executive virtual roundtable (EVR) component, Chris Garabedian, CEO of Xontogeny, a life science accelerator, discusses the last time he attended the annual J.P. Morgan Healthcare conference (JPM) in person (i.e., 2019) and why. He provides perspective as to who should go in-person and why, the overall JPM gathering, and how the event has evolved. Adding to the conversation are Laurie Stelzer, EVP and CFO of Arena Pharmaceuticals; and Stephen From, chairman, EyeGate Pharma.